These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 6841855)

  • 1. Effects of age on responses to treatment and survival of patients with multiple myeloma.
    Cohen HJ; Silberman HR; Forman W; Bartolucci A; Liu C
    J Am Geriatr Soc; 1983 May; 31(5):272-7. PubMed ID: 6841855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adriamycin, 1,3-bis (2-chloroethyl) 1 nitrosourea (BCNU, NSC No. 409962), cyclophosphamide plus prednisone (ABC-P) in melphalanresistant multiple myeloma.
    Presant CA; Klahr C
    Cancer; 1978 Sep; 42(3):1222-7. PubMed ID: 698913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age and the treatment of multiple myeloma. Southeastern Cancer Study Group experience.
    Cohen HJ; Bartolucci A
    Am J Med; 1985 Sep; 79(3):316-24. PubMed ID: 3898836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase III study of intermittent carmustine (BCNU), cyclophosphamide, and prednisone versus intermittent melphalan and prednisone in myeloma.
    Abramson N; Lurie P; Mietlowski WL; Schilling A; Bennett JM; Horton J
    Cancer Treat Rep; 1982 Jun; 66(6):1273-7. PubMed ID: 7044535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The addition of interferon or high dose cyclophosphamide to standard chemotherapy in the treatment of patients with multiple myeloma: phase III Eastern Cooperative Oncology Group Clinical Trial EST 9486.
    Oken MM; Leong T; Lenhard RE; Greipp PR; Kay NE; Van Ness B; Keimowitz RM; Kyle RA
    Cancer; 1999 Sep; 86(6):957-68. PubMed ID: 10491521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cisplatin, BCNU, cyclophosphamide, and prednisone in multiple myeloma.
    Broun GO; Petruska PJ; Hiramoto RN; Cohen HJ
    Cancer Treat Rep; 1982 Feb; 66(2):237-42. PubMed ID: 7034931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination chemotherapy for multiple myeloma with melphalan, prednisone, cyclophosphamide, vincristine, and carmustine (BCNU) (M-2 protocol).
    Tirelli U; Crivellari D; Carbone A; Veronesi A; Galligioni E; Trovò MG; Tumolo S; Grigoletto E
    Cancer Treat Rep; 1982 Nov; 66(11):1971-3. PubMed ID: 6897205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of melphalan and prednisone with vincristine, carmustine, melphalan, cyclophosphamide, and prednisone in the treatment of multiple myeloma: results of Eastern Cooperative Oncology Group Study E2479.
    Oken MM; Harrington DP; Abramson N; Kyle RA; Knospe W; Glick JH
    Cancer; 1997 Apr; 79(8):1561-7. PubMed ID: 9118039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vincristine, BCNU, doxorubicin, and prednisone (VBAP) combination in the treatment of relapsing or resistant multiple myeloma: a Southwest Oncology Group study.
    Bonnet J; Alexanian R; Salmon S; Bottomley R; Amare M; Haut A; Dixon D
    Cancer Treat Rep; 1982 Jun; 66(6):1267-71. PubMed ID: 7044534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of oral melphalan, CCNU, and BCNU with and without vincristine and prednisone in the treatment of multiple myeloma. Cancer and Leukemia Group B experience.
    Cornwell GG; Pajak TF; Kochwa S; McIntyre OR; Glowienka LP; Brunner K; Rafla S; Silver RT; Cooper MR; Henderson E; Kyle RA; Haurani FI; Cuttner J
    Cancer; 1982 Nov; 50(9):1669-75. PubMed ID: 7116299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of multiple myeloma in elderly people: long-term results in 178 patients.
    Bladé J; Muñoz M; Fontanillas M; San Miguel J; Alcalá A; Maldonado J; Besses C; Moro MJ; García-Conde J; Rozman C; Montserrat E; Estapé J
    Age Ageing; 1996 Sep; 25(5):357-61. PubMed ID: 8921139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved survival times in multiple myeloma treated with melphalan, prednisone, cyclophosphamide, vincristine and BCNU: M-2 protocol.
    Case DC; Lee DJ; Clarkson BD
    Am J Med; 1977 Dec; 63(6):897-903. PubMed ID: 605911
    [No Abstract]   [Full Text] [Related]  

  • 13. [Combination chemotherapy of multiple myeloma--BCNU.cyclophosphamide.procarbazine.prednisolone and MCNU.cyclophosphamide.procarbazine.prednisolone therapy].
    Uzuka Y; Saito Y; Takahashi H; Komatsu M; Ito T
    Gan To Kagaku Ryoho; 1989 Jun; 16(6):2269-73. PubMed ID: 2735769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elderly patients with aggressive non-Hodgkin's lymphoma treated with CHOP chemotherapy plus granulocyte-macrophage colony-stimulating factor: identification of two age subgroups with differing hematologic toxicity.
    Gómez H; Mas L; Casanova L; Pen DL; Santillana S; Valdivia S; Otero J; Rodriguez W; Carracedo C; Vallejos C
    J Clin Oncol; 1998 Jul; 16(7):2352-8. PubMed ID: 9667250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination chemotherapy for multiple myeloma with melphalan, ifosfamide, prednisolone, nitrosourea and vincristine.
    Ishii H
    Acta Med Okayama; 1988 Jun; 42(3):175-82. PubMed ID: 3165236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alternating combination VCMP/VBAP chemotherapy versus melphalan/prednisone in the treatment of multiple myeloma: a randomized multicentric study of 487 patients.
    Bladé J; San Miguel JF; Alcalá A; Maldonado J; Sanz MA; García-Conde J; Moro MJ; Alonso C; Besalduch J; Zubizarreta A
    J Clin Oncol; 1993 Jun; 11(6):1165-71. PubMed ID: 8501503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Standard treatment of multiple myeloma.
    Oken MM
    Mayo Clin Proc; 1994 Aug; 69(8):781-6. PubMed ID: 8035637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimizing quality of life in multiple myeloma patients: current options, challenges and recommendations.
    Maes H; Delforge M
    Expert Rev Hematol; 2015 Jun; 8(3):355-66. PubMed ID: 25739703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of multiple myeloma in older adults: Gaining ground with geriatric assessment.
    Wildes TM; Campagnaro E
    J Geriatr Oncol; 2017 Jan; 8(1):1-7. PubMed ID: 27118356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thalidomide in patients with advanced multiple myeloma: a study of 83 patients--report of the Intergroupe Francophone du Myélome (IFM).
    Yakoub-Agha I; Attal M; Dumontet C; Delannoy V; Moreau P; Berthou C; Lamy T; Grosbois B; Dauriac C; Dorvaux V; Bay JO; Monconduit M; Harousseau JL; Duguet C; Duhamel A; Facon T
    Hematol J; 2002; 3(4):185-92. PubMed ID: 12189564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.